GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 4,090.00
+295.00 (7.77%)
At close: Jan 27, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 132.74 billion as of January 30, 2026. Its market cap has increased by 197.01% in one year.
Market Cap
132.74B
Enterprise Value
127.40B
Revenue
8.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,090.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 132.74B, a decrease of -8.86%. That is a compound annual growth rate of -2.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 132.74B | 13.71% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 480.23B |
| Dx & Vx | 314.97B |
| Cytogen | 182.02B |
| Green Cross Medical Science | 84.68B |
| HLB PANAGENE Co., LTD. | 81.94B |
| Protia | 73.14B |
| Seoulin Bioscience | 59.67B |
| GeneMatrix | 49.45B |